Ethics approval and consent to participate
The trial was approved by REC (Norwegian regional committee for medical and health research ethics) with ID number 2017/97. A written informed consent was obtained from all participants. All methods were carried out in accordance with relevant guidelines and regulations in the Declaration of Helsinki.